Physician

Daniel Bintrim, M.D.

According to 2025 Medicare claims, Daniel Bintrim, M.D. (NPI: 1639531452) practices pain management in the Greensboro-High Point, NC market, with the plurality of this provider's patient population coming from Guilford, NC. This provider's primary affiliated billing organization is WAKE FOREST UNIVERSITY HEALTH SCIENCES (NPI: 1003803032; TIN: 223849199) and primary practice location at 27265-8356. Bintrim is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Bintrim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 1,651 HCPCS/CPT codes, and received $54,411 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 910 prescription claims across 291 beneficiaries totaling $55,857 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 22 records totaling $1,087. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $187 to $55,857. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$27K$54K2021 Medicare payment: $25,986 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $47,258 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $53,494 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $54,411 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021106268$25,986
2022162548$47,258
2023153692$53,494
20241481,651$54,411

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$56K2016 Drug cost: $187 (USD; Tot_Drug_Cst)2017 Drug cost: $959 (USD; Tot_Drug_Cst)2020 Drug cost: $33,400 (USD; Tot_Drug_Cst)2021 Drug cost: $44,013 (USD; Tot_Drug_Cst)2022 Drug cost: $33,453 (USD; Tot_Drug_Cst)2023 Drug cost: $34,571 (USD; Tot_Drug_Cst)2024 Drug cost: $55,857 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R14$187
2017N/R17$959
2018N/RN/RN/R
2019N/RN/RN/R
2020213371$33,400
2021262583$44,013
2022185469$33,453
2023219641$34,571
2024291910$55,857

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4949$116
27096Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance3335$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5071$88
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3038$65
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's97146$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BelbucaBuprenorphine Hcl34976$24,426
BuprenorphineBuprenorphine32896$8,593
PregabalinPregabalin933,315$5,591
CelecoxibCelecoxib341,340$2,867
GabapentinGabapentin1104,415$1,856

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$1,087Nevro Corp.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Daniel Bintrim, M.D.?

Tedicare shows public-source Medicare data for Daniel Bintrim, M.D. (NPI 1639531452), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Bintrim, M.D. have ACO affiliation data?

Daniel Bintrim, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Daniel Bintrim, M.D.?

Daniel Bintrim, M.D. is linked to WAKE FOREST UNIVERSITY HEALTH SCIENCES (billing NPI 1003803032) in the available physician profile data.

Does Daniel Bintrim, M.D. have Open Payments data?

Daniel Bintrim, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.